Meeting Information
Course Directors
Faculty
- International Faculty
- Korean Faculty
Focus
Scientific Program
• Meeting at a Glance
Program
  - Main Arena
  - Coronary Arena
  - Endovascular Arena
  - Symposium Arena
  - Tutorial Arena
  - Breakfast Meetings
  - Satellite Symposia
  - Oral Abstract Presentation
  - Case Presentation
  - Live Case Operators
  - Conference for
    Cardiovascular Nurse
    & Technologist

  - Cardiopulmonary
     Rehabilitation Workshop

  - Clinical Exercise
    Specialist (CES) Workshop
Live Case Demonstration
E-Poster Abstracts
Live Case Transmission
    Sites
Factoid
Syllabus
Summit Live Interview
Gallery
Daily Newspaper
Advance Registration
Housing
Exhibition
- Exhibition Information
- Exhibitor's List & Floor Plan
Learning Center
Eco-Friendly Convention
     : Yes, Green!
Tour Information
- Korea, Sparkling
- About Seoul
- Visa
- Tour Program
Contact Us
About CVRF
2009 Brochure Download



Lunchtime Activities & Evening Symposia

Wednesday| April 22, 2009

Lunchtime Activities
12:45 PM-1:45 PM

#1. New Statin Role in Atherosclerosis
Coronary Arena, Level 1
Co-sponsored by AstraZeneca Korea
Moderator: Ki Bae Seung
12:45 PM Welcome Address Ki Bae Seung
12:50 PM Optimal Lipid Management: Recent Update from New Trials Peter J. Lansberg
1:10 PM Q & A  
1:30 PM Adjourn  
   
#2. Clinical Impact of the Pro-Healing Stent and Beyond
Endovascular Arena, Level 1
Co-sponsored by Orbus Neich Medical Korea, Ltd
Chairperson: Seung-Jung Park
12:45 PM Opening Address Seung-Jung Park
12:50 PM Development of a Novel Sirolimus Eluting Pro-Healing Stent Juan Granada
1:05 PM Genous Stent in Real-World Experience and TRIAS HR Pilot Study Long Term Follow Up Margo Klomp
1:20 PM AMI Intervention in DES Era and Beyond Harry Suryapranata
1:35 PM Q & A followed by Closing Remarks Seung-Jung Park
1:45 PM Adjourn  
   
#3. The Future of Drug-Eluting Stent- BioMatrix™: The New Biodegradable Abluminally Coated Drug-Eluting Stent with Completely Biodegradable Polymer and a Long Term Safety Profile of a Bare-Metal Stent
Room 1-1(Calla Room), Level 1
Co-Sponsored by Biosensors & Jung Sung Medical
Moderators: Yangsoo Jang, Junghan Yoon
12:45 PM Welcome and Opening Address  
12:50 PM Assessment of LEADERS 12 Months Result Patrick W. Serruys
1:05 PM LEADERS: Analysis of 9 Months OCT Results Patrick W. Serruys
1:15 PM Asia Pacific BioMatrix™ Clinical Results Teguh Santoso
1:25 PM BioMatrix™: The New Biodegradable Abluminally Coated DES BioMatrixTM Clinical Program Teguh Santoso
1:35 PM Questions & Answers  
1:40 PM Conclusion & Closing Remarks  
1:45 PM Adjourn  
   
#4. Prasugrel: A Novel Thienopyridine Antiplatelet Agent
Room 2-1(Presidio 1 & 2), Level 2
Sponsored by Lilly Korea & Daiichi Sankyo Korea
Moderators: Roxana Mehran, Seong-Wook Park
12:45 PM Welcome Address Seong-Wook Park
12:50 PM New Paradigms in Treatment of ACS/AMI Roxana Mehran
1:10 PM Potential Ethnic Difference with Prasugrel Between Caucasian and Asian Populations Ronan Kelly
1:30 PM Q & A followed by Closing Remarks  
1:40 PM Adjourn  
   
#5. Vulnerable Plaque: Identification & Therapeutic Intervention
Symposium Arena, Level 3
Co-sponsored by Clinical Research Center for Ischemic Heart Disease, The Korea Ministry of Health and Welfare
Moderators: Gary S. Mintz, Cheol Whan Lee
12:45 PM Mechanisms of Plaque Destabilization: Pathologic Observation Renu Virmani
1:00 PM In Search of Vulnerable Plaque: Summary of Current Issues Gary S. Mintz
1:15 PM Regional Therapy: FIH Experience of A Novel Self Expandable Nitinol Device Juan Granada
1:30 PM Systemic Therapy for Plaque Stabilization: New Drugs Targeting LP-PLA2 Patrick W. Serruys
1:45 PM Discussion  
1:50 PM Adjourn  
   
#6. Now Is the Switching Point to Move to the Bivalirudin Monotheraphy
Tutorial Arena, Level 4
Sponsored by Asia Pharm.Ind.Co.,Ltd
Moderators: Young-Hak Kim, Gregg W. Stone
12:45 PM Welcome Address Young-Hak Kim
12:50 PM STEMI and NSTEMI Pharmacology Confusion: How to Choose and Use Antithrombins (Unfractionated and Low Molecular Weight Heparins, Bivalirudin, Fondaparinux) and Antiplatelet Agents (Aspirin, Clopidogrel, and Prasugrel) Gregg W.Stone
1:10 PM Does the Efficacy of Bivalirudin During PCI Depend on Clopidogrel Pretreatment? Matthew Price
1:30 PM Q & A  
1:40 PM Adjourn  
   

Evening Satellite Symposia
6:30 PM-9:00 PM

#1. Next Generation DES: Today and Tomorrow
Coronary Arena, Level 1
Organized by CVRF, Supported by Educational Grant from Abbott Vascular & Crossroads Institutes
Moderators: Seung-Jung Park, Gregg W. Stone
Panelists: Hyeon-Cheol Gwon, Hweung Kon Hwang, Myung-Ho Jeong, Hyo-Soo Kim, Do Sun Lim, Ki Bae Seung, Junghan Yoon
6:45 PM Reception Dinner & Opening Moderator
7:15 PM The Latest Updates in DES Clinical Data Gregg W. Stone
7:35 PM Real World Experiences of 2nd Generation DES Ian T. Meredith
7:55 PM Bioabsorbable Stents- "The New Frontier in Interventional Cardiology" Chuck Simonton
8:15 PM Q & A  
8:35 PM Adjourn  
   
#2. The Strength of Evidence
Endovascular Arena, Level 1
Sponsored by Johnson & Johnson Medical Korea
Moderator: Seong-Wook Park
Panelists: Youngkeun Ahn, Myeong-Ki Hong, Yangsoo Jang, Chong-Jin Kim
6:30 PM Opening Seong-Wook Park
6:35 PM Long-Term Clinical Outcome of Sirolimus-Eluting Stent over 6 Years Martin B. Leon
6:55 PM Panel Discussion  
7:05 PM Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation Takeshi Kimura
7:25 PM Panel Discussion  
7:35 PM The Impact of Diabetes in the DES Long-Term Outcome Seung-Jung Park
8:00 PM Panel Discussion  
8:10 PM Cordis Next-Generation DES Technology Robert Falotico
8:30 PM Wrap up and Adjourn  
     

Thurs day| April 23, 2009

Lunchtime Activities
12:30 PM-1:30 PM

#1. Strategic Approaches to Obtain Better and Earlier CV Outcome
Coronary Arena, Level 1
Co-sponsored by Pfizer Pharmaceutical Korea Ltd.
Moderator: Jeong Euy Park
12:30 PM Opening Address Jeong Euy Park
12:35 PM Strategic Approaches to Obtain Better and Earlier CV Outcome Weon Kim
1:05 PM Q & A  
1:20 PM Adjourn  
   
#2. What's the Ideal Treatment with Antiplatelet?
Endovascular Arena, Level 1
Sponsored by Bristol-Myers Squibb Korea
Moderator: Junghan Yoon
12:30 PM Welcome Address Junghan Yoon
12:35 PM Anti-platelet Therapies in Cardiovascular Disease: From Stable CAD to ACS and Afib Roxana Mehran
12:55 PM What Is the Optimal Duration of DAPT Following DES Treatment? David E. Kandzari
1:15 PM Q & A  
1:30 PM Adjourn  
   
#3. What Is the Optimal Antiplatelet Therapy in High Risk Patient After DES Implantation?
Room 1-1(Calla Room), Level 1
Co-sponsored by Korea Otsuka Pharmaceutical Co., Ltd. 
Moderators: Alexandra J. Lansky, Seong-Wook Park
Panelists:
12:30 PM Welcome address Seong-Wook Park
12:35 PM Tailoring Treatment to Risk in Antiplatelet Therapy Alexandra J. Lansky
12:55 PM The Role of Triple Antiplatelet Therapy in Patients with High Risk Young-Hoon Jeong
1:15 PM Q & A  
1:30 PM Adjourn  
   
#4. Nobori – Clinical Data Update
Room 2-1(Presidio 1 & 2), Level 2
Co-sponsored by Terumo Korea Corporation
Moderator: Takeshi Kimura
12:30 PM Stentdesign Comparison and Clinical Perspectives Yutaka Hikichi
12:50 PM NOBORI -Clinical Studies Updates Gian Battista Danzi
1:15 PM Future Clinical Study for Nobori Stent in Korea Seung-Jung Park
1:23 PM Discussion  
1:30 PM Adjourn  
   
#5. Beyond the Horizon - Inspire Your Confidence
Symposium Arena, Level 3
Sponsored by Boston Scientific Korea
Moderators: Seung-Jung Park, Patrick W. Serruys
12:30 PM Opening Remarks & Welcome Address Seung-Jung, Park
12:35 PM SYNTAX - Data Synthesis and Clinical Recommendations Patrick W. Serruys
1:05 PM Boston Scientific DES - Current & Future Perspectives Keith D. Dawkins
1:20 PM Q & A  
1:30 PM Adjourn  
   
#6. Advances in the Treatment of Chronic Limb Ischemia - Current Treatment in CLI
Tutorial Arena, Level 4
Co-sponsored by Johnson & Johnson Medical Korea (Endovascular)
Moderator: Taehoon Ahn
Panelists: Seung-Whan Lee, Seung Hyuk Choi, Tae Won Kwon
12:30 PM Opening Remark Taehoon Ahn
12:35 PM Current Treatment in CLI     Dierk Scheinert
1:05 PM Improved Technical Success and Miterm Patency with Subintimal Angioplasty (Compared to Intraluminal Angioplasty in Long Femoropopliteal Occlusions) Young-Guk Ko
1:15 PM Preliminary Result of Study for Prevalence of Peripheral Vascular Disease by for Screening Test Jang Yong Kim
1:25 PM Q & A  
1:30 PM Adjourn  
   

Evening Satellite Symposia
6:30 PM-9:00 PM

#1. Design for Patient & Lesion Characteristic: Endeavor & Endeavor Resolute Perspective
Coronary Arena, Level 1
Co-sponsored by Medtronic, Inc.
Moderators: Yangsoo Jang, Ian T. Meredith
Panelists: Raoul Bonan, Myeong-Chan Cho, Hyo-Soo Kim, Micheal Kang-Yin Lee, Ki Bae Seung
6:30 PM Dinner Reception & Welcome Address  
7:00 PM Endeavor Resolute: The Next Frontier Ian T. Meredith
7:20 PM Endeavor Program Overview Martin B. Leon
7:40 PM Safety Issue in DES Era David E. Kandzari
8:00 PM Comparison of Sirolimus- and Paclitaxel-Eluting Stents vs Zotarolimus-Eluting Stents in Real World Practice: The ZEST Randomized Controlled Trial Seung-Jung Park
8:20 PM What I like Most on Endeavor Stent Based on the DATE Registry Hyeon-Cheol Gwon
8:40 PM Q & A  
8:50 PM Adjourn  
   
#2. Structural Heart Disease Symposium
Endovascular Arena, Level 1
Co-sponsored by AGA Corporation
Moderators:Teiji Akagi, I-Seok Kang
Panelists: Mazeni Alwi, Jae-Young Choi, Kritvikrom Durongpisitkul, Hong Gu, Soo-Jin Kim, Xiangqing Kong
6:30 PM Dinner  
7:00 PM Device Closure of Difficult and Large ASD's-Techniques and Tricks Masood Sadiq
7:15 PM ASD Device Closure: Erosions-Do We Really Have To Worry? How To Minimize Erosions? Ziyad M. Hijazi
7:30 PM Left Lateral Approach to Pericardiocentesis in Children and Infants Frank Ing
7:45 PM Conduction Abnormalities Following Device Closure of Membranous VSD Mazeni Alwi
8:00 PM Can We Lower the Risk of Catheter Intervention for Congenital Heart Disease? Toshio Nakanishi
8:15 PM Stenting in Coarctation of the Aorta-Shall All Adolescents and Adults Recieve Covered Stent? Masood Sadiq
8:30 PM Transcatheter Closure of Subarterial VSD Using Pfm Coil Kritvikrom Durongpisitkul
8:45 PM Discussion  
9:00 PM Adjourn